华中科技大学主页平台管理系统 Liang Luo--English homepage-- Recent progress on nanoparticle-based drug delivery systems for cancer therapy

Liang Luo

Professor

Supervisor of Doctorate Candidates

Supervisor of Master's Candidates

Gender:Male

Status:Employed

Department:School of Life Science and Technology

Education Level:Postgraduate (Doctoral)

Discipline:Biomedical Engineering

Details >

Recommended Ph.D.Supervisor Recommended MA Supervisor Team member

Paper Publications

Current position: English homepage > Scientific Research > Paper Publications

Recent progress on nanoparticle-based drug delivery systems for cancer therapy

Release time:2020-12-24 Hits:

Journal:Cancer Biology & Medicine

Included Journals:SCI

Volume:14

Issue:3

Page Number:228-241

ISSN No.:2095-3941

DOI number:10.20892/j.issn.2095-3941.2017.0052

Date of Publication:2017-05-24

Impact Factor:4.607

Abstract:The development of cancer nanotherapeutics has attracted great interest in the recent decade. Cancer nanotherapeutics have overcome several limitations of conventional therapies, such as nonspecific biodistribution, poor water solubility, and limited bioavailability. Nanoparticles with tuned size and surface characteristics are the key components of nanotherapeutics, and are designed to passively or actively deliver anti-cancer drugs to tumor cells. We provide an overview of nanoparticle-based drug delivery methods and cancer therapies based on tumor-targeting delivery strategies that have been developed in recent years.

Links to published journals:http://cancerbiomed.org/index.php/cocr/article/view/1045/1171

Pre One:Conformation-Dependent Manipulation of Human Islet Amyloid Polypeptide Fibrillation by Shiitake-Derived Lentinan

Next One:Efficient Radical-Enhanced Intersystem Crossing in an NDI-TEMPO Dyad: Photophysics, Electron Spin Polarization, and Application in Photodynamic Therapy